| Literature DB >> 28612707 |
Chih-Ming Chen1, Chih-Ho Lai2, Hwa-Jene Wu3, Lii-Tzu Wu4.
Abstract
BACKGROUND: Proteus mirabilis is an opportunistic pathogen, commonly associated with complicated urinary tract infections (UTIs). UTIs caused by multidrug-resistant Proteus mirabilis have increased worldwide. Multidrug-resistance of Gram-negative enteric bacteria is usually associated with class 1 integrons. PURPOSES: To investigate the prevalence and characterize gene cassettes of class 1 integrons in multidrug-resistant P. mirabilisEntities:
Year: 2017 PMID: 28612707 PMCID: PMC5479437 DOI: 10.1051/bmdcn/2017070202
Source DB: PubMed Journal: Biomedicine (Taipei) ISSN: 2211-8020
Susceptibility testing results of 76 intll-positive and 238 intll-negative Proteus mirabilis isolates.
| intl1-positive isolates ( | intl1-negative isolates (n = 238) ESBL positive n = 24 | |||
|---|---|---|---|---|
| Antibiotic | MIC (μg/ | Resistance | MIC (μg/ | Resistance |
| Amoxicillin-clavulanic acid | 16 (4), ≤ 8 (72) | 5.2% | 16 (2), ≤ 8 (236) | 0.1% |
| Piperacillin | ≥ 256 (75), 64 (1) | 98.7% | ≥ 256 (35), 32 (203) | 14.7% |
| Cefotaxime | ≥ 256 (29), 64 (13), 16–32 (12), ≤ 2 (22) | 71.1% | ≥ 256 (10), 64 (7), 16-32 (7), ≤ 2 (214) | 10.1% |
| Ceftazidime | 2(1), ≤ 0.5 (75) | 1.3% | ≤ 0.5 (238) | 0% |
| Cefepime | 32 (1), 4 (3), ≤ 2 (72) | 5.3% | 4 (1), ≤ 2 (237) | ~0% |
| Cefoxitin | 16–32 (3), ≤ 8 (73) | 3.9% | 16 (1), ≤ 8 (237) | ~0% |
| Meropenem | ≤ 0.5 (76) | 0% | ≤ 0.5 (238) | 0% |
| Gentamicin | ≥ 16 (66), ≤ 2 (10) | 86.8% | ≥ 16 (21), ≤ 2 (217) | 8.8% |
| Amikacin | ≥ 16 (65), ≤ 2 (11) | 85.5% | ≥ 16 (17), ≤ 2 (221) | 7.1% |
| Ciprofloxacin | ≥ 4 (28), ≤ 1 (48) | 36.8% | ≥ 4 (11), ≤ 1 (227) | 4.6% |
The chi-square test was employed to compare the antimicrobial resistance rate between intll-positive and intll-negative P. mirabilis isolates. Susceptibility was determined according to the interpretive criteria of the Clinical and Laboratory Standards Institute 2005.
p-value is less than 0.05.
Resistance phenotype of class 1 integrons and their gene cassettes in76 intl1-positive Proteus mirabilis isolates.
| Integrons group (no. of isolates) | Amplicon size of integrons (Kb) | Gene cassette(s) | Resistance phenotype | ERIC type (number) |
|---|---|---|---|---|
| A single amplicon produced | ||||
| 1 (1) | 3.5 | aadB-cat-oxa10-aadA1 | KmCAmSmSp | G (1) |
| 2 (1) | 3.2 | aac(6’)-Ib-aacA7-cmlA | GmCTpSmSp | H (1) |
| 3 (38) | 2.1 | dfr12-orfF-aadA2 | TpSmSp | C (9), D (4), E (2), G(21), H (1), ND(1) |
| 4 (8) | 1.8 | aadB-aadA2 | GmSmSp | B (2), G (4), ND (2) |
| 5 (5) | 1.8 | dfrA1-aadA1a | TpSmSp | A (1), B (1), G (3) |
| 6 (3) | 1.0 | aadA1 | SmSp | E (1), G (2) |
| 7 (5) | 0.9 | dfr12 | Tp | C (2), D (1), ND(2) |
| Two or more amplicons produced | ||||
| 8 (5) | 2.1/0.9 | dfr12-orfF-aadA2/dfr12 | TpSmSp | C (2), D (2), G (1) |
| 9 (3) | 2.1/1.8 | dfr12-orfF-aadA2/aadB-aadA2 | TpSmSp | C (1), F (1), G(1) |
| 10 (2) | 2.1/1.8/0.9 | dfr12-orfF-aadA2/aadB-aadA2/ dfr12 | TpSmSpGm | C (1), G (1) |
| 11 (1) | 3.1/2.1/1.8 | aadB-cat-aadA1a/dfr12-orfF-aadA2/dfrA1- aadA1a | KmTpSmSp | G (1) |
| Negative for cassette regions | ||||
| 12 (4) | 0.15 | – | – | C (1), D (2), ND(1) |
ND, not detected.
Am, ampicillin; C, chloramphenicol; Gm, gentamicin; Km, kenamycin; Tp, trimethoprim; Sm, streptomycin; Sp, spectinomycin.
Fig. 1Fingerprinting patterns of eight ERIC types of class 1 integron-positive P. mirabilis isolates in this study. Lane M1, 1 Kb molecular size marker. Lane M2, 100 bp molecular size marker. Lanes A-H, fingerprinting patterns of ERIC types A-H, respectively.